Alzheimer's Drug Discovery Foundation Funds P2D to Develop Anti-Alzheimer's Disease Drug
Alzheimer's Drug Discovery Foundation Funds Varinel to Develop Drugs for Neurodegenerative Disease
OSTA Receives Funding from Institute for the Study of Aging
Cellumen Partners with Alzheimer's Drug Discovery Foundation to Develop New Assays for Early Treatment of Alzheimer's
RemeGenix Funded by the Alzheimer's Drug Discovery Foundation to commercialize BRI2 peptides for use in treating Alzheimer's disease
OLIGOMERIX funded by the Alzheimer's Drug Discovery Foundation to evaluate compounds active against tau oligomers, a novel target for therapeutic development
Alzheimer's Drug Discovery Foundation Funds PharmatrophiX to Develop Drugs to Prevent Neurodegenerative Disease
Alzheimer's Drug Discovery Foundation and Elan Announce Winners of Third Annual Novel Discovery Award Program
Awards for Drug Discovery Research for Frontotemporal Dementia Announced
Key International Thought Leaders Convening to Accelerate Drug Discovery for Neurodegenerative Diseases
Alzheimer's Disease Drug Discovery Foundation Appoints New Managing Director and Chief Operating Officer
Alzheimer's Drug Discovery Foundation Invites Scientists to Apply for Grant Award Program
Alzheimer's Drug Discovery Foundation and The
Association for Frontotemporal Dementias Invite Scientists to Apply for FTD
Grant Award Program
Read Release
The ADDF announces support of the NIH Brain Imaging Study.
Read Release
Winners of a new Drug Discovery Grant
Program are announced at the Annual Awards Luncheon.
Read Release
New Study Finds Health Care Costs Associated with Vascular Dementia are Higher than Alzheimer’s Disease.
Read Release